Literature DB >> 15489312

Insulin-like growth factor I: the yin and yang of muscle atrophy.

Maria F Chacon Heszele, S Russ Price.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15489312     DOI： 10.1210/en.2004-1037

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  16 in total

Review 1.  Anabolic and anticatabolic agents in critical care.

Authors:  Mile Stanojcic; Celeste C Finnerty; Marc G Jeschke
Journal:  Curr Opin Crit Care       Date:  2016-08       Impact factor: 3.687

Review 2.  What, how, and how much should patients with burns be fed?

Authors:  Felicia N Williams; Ludwik K Branski; Marc G Jeschke; David N Herndon
Journal:  Surg Clin North Am       Date:  2011-06       Impact factor: 2.741

Review 3.  Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs?

Authors:  Gerd G Gauglitz; Felicia N Williams; David N Herndon; Marc G Jeschke
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-03       Impact factor: 4.294

Review 4.  Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns.

Authors:  Eva C Diaz; David N Herndon; Craig Porter; Labros S Sidossis; Oscar E Suman; Elisabet Børsheim
Journal:  Burns       Date:  2014-11-16       Impact factor: 2.744

5.  Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.

Authors:  P Sarzi-Puttini; F Atzeni; J Schölmerich; M Cutolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

6.  Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors.

Authors:  Cristina Borselli; Hannah Storrie; Frank Benesch-Lee; Dmitry Shvartsman; Christine Cezar; Jeff W Lichtman; Herman H Vandenburgh; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

7.  Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.

Authors:  Inga-Lill Engvall; Birgitta Tengstrand; Kerstin Brismar; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2010-10-21       Impact factor: 5.156

8.  Effects of oral sodium bicarbonate in patients with CKD.

Authors:  Matthew K Abramowitz; Michal L Melamed; Carolyn Bauer; Amanda C Raff; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 8.237

Review 9.  The hypermetabolic response to burn injury and interventions to modify this response.

Authors:  Felicia N Williams; David N Herndon; Marc G Jeschke
Journal:  Clin Plast Surg       Date:  2009-10       Impact factor: 2.017

10.  Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia.

Authors:  Felipe E Pedroso; Paul B Spalding; Michael C Cheung; Relin Yang; Juan C Gutierrez; Andrea Bonetto; Rui Zhan; Ho Lam Chan; Nicholas Namias; Leonidas G Koniaris; Teresa A Zimmers
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-03-29       Impact factor: 12.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.